These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 10986252)
1. Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides. Boshoff HI; Mizrahi V J Bacteriol; 2000 Oct; 182(19):5479-85. PubMed ID: 10986252 [TBL] [Abstract][Full Text] [Related]
2. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide. Sun Z; Zhang Y Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264 [TBL] [Abstract][Full Text] [Related]
3. Purification, gene cloning, targeted knockout, overexpression, and biochemical characterization of the major pyrazinamidase from Mycobacterium smegmatis. Boshoff HI; Mizrahi V J Bacteriol; 1998 Nov; 180(22):5809-14. PubMed ID: 9811635 [TBL] [Abstract][Full Text] [Related]
4. Estimation of pyrazinamidase activity using a cell-free Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881 [TBL] [Abstract][Full Text] [Related]
5. Mycobacterium smegmatis has two pyrazinamidase enzymes, PncA and pzaA. Guo M; Sun Z; Zhang Y J Bacteriol; 2000 Jul; 182(13):3881-4. PubMed ID: 10851013 [TBL] [Abstract][Full Text] [Related]
6. The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organisms. Sun Z; Scorpio A; Zhang Y Microbiology (Reading); 1997 Oct; 143 ( Pt 10)():3367-3373. PubMed ID: 9353938 [TBL] [Abstract][Full Text] [Related]
7. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity. Raynaud C; Lanéelle MA; Senaratne RH; Draper P; Lanéelle G; Daffé M Microbiology (Reading); 1999 Jun; 145 ( Pt 6)():1359-1367. PubMed ID: 10411262 [TBL] [Abstract][Full Text] [Related]
10. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Scorpio A; Zhang Y Nat Med; 1996 Jun; 2(6):662-7. PubMed ID: 8640557 [TBL] [Abstract][Full Text] [Related]
11. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989 [TBL] [Abstract][Full Text] [Related]
12. Metallochaperones Are Needed for Mycobacterium tuberculosis and Escherichia coli Nicotinamidase-Pyrazinamidase Activity. Sheen P; Monsalve A; Campos J; Huerta R; Antiparra R; Arteaga H; Duran P; Bueno C; Kirwan DE; Gilman RH; Zimic M J Bacteriol; 2020 Jan; 202(2):. PubMed ID: 31636108 [No Abstract] [Full Text] [Related]
13. Mutually exclusive genotypes for pyrazinamide and 5-chloropyrazinamide resistance reveal a potential resistance-proofing strategy. Baughn AD; Deng J; Vilchèze C; Riestra A; Welch JT; Jacobs WR; Zimhony O Antimicrob Agents Chemother; 2010 Dec; 54(12):5323-8. PubMed ID: 20876380 [TBL] [Abstract][Full Text] [Related]
14. Genetic and phenotypic characterization of pyrazinamide-resistant mycobacterium tuberculosis complex isolates in Japan. Miyagi C; Yamane N; Yogesh B; Ano H; Takashima T Diagn Microbiol Infect Dis; 2004 Feb; 48(2):111-6. PubMed ID: 14972380 [TBL] [Abstract][Full Text] [Related]
16. pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea. Park SK; Lee JY; Chang CL; Lee MK; Son HC; Kim CM; Jang HJ; Park HK; Jeong SH BMC Infect Dis; 2001; 1():4. PubMed ID: 11429043 [TBL] [Abstract][Full Text] [Related]
17. Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates. Mestdagh M; Realini L; Fonteyne PA; Rossau R; Jannes G; Mijs W; DE Smet KA; Portaels F; Van den Eeckhout E Microb Drug Resist; 2000; 6(4):283-7. PubMed ID: 11272256 [TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene. Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140 [TBL] [Abstract][Full Text] [Related]
19. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand. Jonmalung J; Prammananan T; Leechawengwongs M; Chaiprasert A BMC Microbiol; 2010 Aug; 10():223. PubMed ID: 20727143 [TBL] [Abstract][Full Text] [Related]
20. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide]. Hong CY; Wang F; Gui J; Liu XL Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May; 46(5):436-9. PubMed ID: 22883731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]